Skip to main content

Who, What, When and Where of Parkinson's Diagnosis

March 17, 2016

In this webinar we discuss how we're getting closer to diagnosing Parkinson's earlier, which could help us test therapies to slow or stop the disease process perhaps even before symptoms appear.

Webinar Details


Thursday, March 17, 2016


1 hr


12:00 pm ET

  • Continuing Medical Education Information

    MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

    Date of Original Release: March 17, 2016
    Date CME Credit No Longer Available: March 17, 2018

    Learning Objectives

    At the conclusion of this course, participants should be able to:

    • Discuss how the diagnosis of Parkinson's disease (PD) is currently made.
    • Recognize how incorrect and delayed diagnoses impact clinical care and research in PD.
    • Explain what Dopamine Transporter (DaT) scans are and their current and potential role in PD clinical care and research.
    • Summarize why correct and early diagnosis is important in PD clinical care and research.
    • Identify how researchers are working toward more accurate and earlier diagnoses of PD.
    Target Audience

    This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.


    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Oakstone Publishing, LLC designates this enduring material for 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


    Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.


    Danna Jennings, MD
    Clinical Research Director
    Institute for Neurodegenerative Disorders
    No disclosures

    Samantha Hutten, PhD
    Senior Associate Director, Research Programs
    The Michael J. Fox Foundation
    No disclosures

    Dave Iverson
    No disclosures

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.